Inactive and active states and supramolecular organization of GPCRs: insights from computational modeling

Herein we make an overview of the results of our computational experiments aimed at gaining insight into the molecular mechanisms of GPCR functioning either in their normal conditions or when hit by gain-of-function or loss-of-function mutations. Molecular simulations of a number of GPCRs in their wild type and mutated as well as free and ligand-bound forms were instrumental in inferring the structural features, which differentiate the mutation- and ligand-induced active from the inactive states. These features essentially reside in the interaction pattern of the E/DRY arginine and in the degree of solvent exposure of selected cytosolic domains. Indeed, the active states differ from the inactive ones in the weakening of the interactions made by the highly conserved arginine and in the increase in solvent accessibility of the cytosolic interface between helices 3 and 6. Where possible, the structural hallmarks of the active and inactive receptor states are translated into molecular descriptors useful for in silico functional screening of novel receptor mutants or ligands. Computational modeling of the supramolecular organization of GPCRs and their intracellular partners is the current challenge toward a deep understanding of their functioning mechanisms.

[1]  T. Lazaridis Effective energy function for proteins in lipid membranes , 2003, Proteins.

[2]  Susan R. George,et al.  G-Protein-coupled receptor oligomerization and its potential for drug discovery , 2002, Nature Reviews Drug Discovery.

[3]  E. Freire,et al.  Can allosteric regulation be predicted from structure? , 2000, Proceedings of the National Academy of Sciences of the United States of America.

[4]  Francesca Fanelli,et al.  Adenosine A2A-Dopamine D2 Receptor-Receptor Heteromerization , 2003, Journal of Biological Chemistry.

[5]  K. Nakamura,et al.  Pleiotropic effects of substitutions of a highly conserved leucine in transmembrane helix III of the human lutropin/choriogonadotropin receptor with respect to constitutive activation and hormone responsiveness. , 2001, Molecular endocrinology.

[6]  K. Fuxe,et al.  Combining mass spectrometry and pull-down techniques for the study of receptor heteromerization. Direct epitope-epitope electrostatic interactions between adenosine A2A and dopamine D2 receptors. , 2004, Analytical chemistry.

[7]  F. Fanelli,et al.  The Formation of a Salt Bridge Between Helices 3 and 6 Is Responsible for the Constitutive Activity and Lack of Hormone Responsiveness of the Naturally Occurring L457R Mutation of the Human Lutropin Receptor* , 2005, Journal of Biological Chemistry.

[8]  J. Bockaert,et al.  Molecular tinkering of G protein‐coupled receptors: an evolutionary success , 1999, The EMBO journal.

[9]  Krzysztof Palczewski,et al.  Sequence analyses of G-protein-coupled receptors: similarities to rhodopsin. , 2003, Biochemistry.

[10]  F. Fanelli,et al.  Activation mechanism of human oxytocin receptor: a combined study of experimental and computer-simulated mutagenesis. , 1999, Molecular pharmacology.

[11]  F. Fanelli,et al.  Structural aspects of luteinizing hormone receptor , 2002, Endocrine.

[12]  Marta Filizola,et al.  The study of G‐protein coupled receptor oligomerization with computational modeling and bioinformatics , 2005, The FEBS journal.

[13]  K. Eidne,et al.  G-protein coupled receptor oligomerization in neuroendocrine pathways , 2003, Frontiers in Neuroendocrinology.

[14]  A. Scheer,et al.  The activation process of the alpha1B-adrenergic receptor: potential role of protonation and hydrophobicity of a highly conserved aspartate. , 1997, Proceedings of the National Academy of Sciences of the United States of America.

[15]  M. Caron,et al.  Constitutive activation of the alpha 1B-adrenergic receptor by all amino acid substitutions at a single site. Evidence for a region which constrains receptor activation. , 1992, The Journal of biological chemistry.

[16]  U. Gether Uncovering molecular mechanisms involved in activation of G protein-coupled receptors. , 2000, Endocrine reviews.

[17]  A. Scheer,et al.  Theoretical study on receptor-G protein recognition: new insights into the mechanism of the α1b-adrenergic receptor activation , 1999 .

[18]  Krzysztof Palczewski,et al.  Organization of the G Protein-coupled Receptors Rhodopsin and Opsin in Native Membranes* , 2003, Journal of Biological Chemistry.

[19]  Francesca Fanelli,et al.  Probing Fragment Complementation by Rigid-Body Docking: in Silico Reconstitution of Calbindin D9k , 2005, J. Chem. Inf. Model..

[20]  Kurt Kristiansen,et al.  Molecular mechanisms of ligand binding, signaling, and regulation within the superfamily of G-protein-coupled receptors: molecular modeling and mutagenesis approaches to receptor structure and function. , 2004, Pharmacology & therapeutics.

[21]  H. Hamm,et al.  The 2.0 Å crystal structure of a heterotrimeric G protein , 1996, Nature.

[22]  Z. Weng,et al.  A novel shape complementarity scoring function for protein‐protein docking , 2003, Proteins.

[23]  S. W. Lin,et al.  Specific tryptophan UV-absorbance changes are probes of the transition of rhodopsin to its active state. , 1996, Biochemistry.

[24]  K. Palczewski,et al.  Crystal Structure of Rhodopsin: A G‐Protein‐Coupled Receptor , 2002, Chembiochem : a European journal of chemical biology.

[25]  C. Brooks,et al.  An implicit membrane generalized born theory for the study of structure, stability, and interactions of membrane proteins. , 2003, Biophysical journal.

[26]  F. Fanelli,et al.  A Model for Constitutive Lutropin Receptor Activation Based on Molecular Simulation and Engineered Mutations in Transmembrane Helices 6 and 7* , 2002, The Journal of Biological Chemistry.

[27]  L. Devi,et al.  G-protein-coupled receptor dimerization: modulation of receptor function. , 2001, Pharmacology & therapeutics.

[28]  Michel Bouvier,et al.  Emerging role of homo- and heterodimerization in G-protein-coupled receptor biosynthesis and maturation. , 2005, Trends in pharmacological sciences.

[29]  Francesca Fanelli,et al.  Prediction of MEF2A-DNA interface by rigid body docking: a tool for fast estimation of protein mutational effects on DNA binding. , 2006, Journal of structural biology.

[30]  J. Ballesteros,et al.  Activation of the β2-Adrenergic Receptor Involves Disruption of an Ionic Lock between the Cytoplasmic Ends of Transmembrane Segments 3 and 6* , 2001, The Journal of Biological Chemistry.

[31]  A. Scheer,et al.  Mutational and computational analysis of the alpha(1b)-adrenergic receptor. Involvement of basic and hydrophobic residues in receptor activation and G protein coupling. , 2001, The Journal of biological chemistry.

[32]  Luigi F Agnati,et al.  Molecular Mechanisms and Therapeutical Implications of Intramembrane Receptor/Receptor Interactions among Heptahelical Receptors with Examples from the Striatopallidal GABA Neurons , 2003, Pharmacological Reviews.

[33]  C. Flanagan,et al.  A GPCR That Is Not “DRY” , 2005, Molecular Pharmacology.

[34]  I. Alves,et al.  Phosphatidylethanolamine enhances rhodopsin photoactivation and transducin binding in a solid supported lipid bilayer as determined using plasmon-waveguide resonance spectroscopy. , 2005, Biophysical journal.

[35]  Wataru Nemoto,et al.  Prediction of interfaces for oligomerizations of G‐protein coupled receptors , 2004, Proteins.

[36]  Francisco Ciruela,et al.  Regulation of heptaspanning-membrane-receptor function by dimerization and clustering. , 2003, Trends in biochemical sciences.

[37]  Francesca Fanelli,et al.  Structural features of the inactive and active states of the melanin‐concentrating hormone receptors: Insights from molecular simulations , 2004, Proteins.

[38]  R. Lefkowitz The superfamily of heptahelical receptors , 2000, Nature Cell Biology.

[39]  Bryan L Roth,et al.  Evidence for a Model of Agonist-induced Activation of 5-Hydroxytryptamine 2A Serotonin Receptors That Involves the Disruption of a Strong Ionic Interaction between Helices 3 and 6* 210 , 2002, The Journal of Biological Chemistry.

[40]  R. Crouch,et al.  Probing rhodopsin-transducin interactions by surface modification and mass spectrometry. , 2004, Biochemistry.

[41]  A. Valencia,et al.  Automatic methods for predicting functionally important residues. , 2003, Journal of molecular biology.

[42]  Christopher A Reynolds,et al.  Toward the active conformations of rhodopsin and the β2‐adrenergic receptor , 2004, Proteins.

[43]  Z. Weng,et al.  ZDOCK: An initial‐stage protein‐docking algorithm , 2003, Proteins.

[44]  K. Fuxe,et al.  Homodimerization of adenosine A2A receptors: qualitative and quantitative assessment by fluorescence and bioluminescence energy transfer , 2003, Journal of neurochemistry.

[45]  Orkun S. Soyer,et al.  Dimerization in aminergic G-protein-coupled receptors: application of a hidden-site class model of evolution. , 2003, Biochemistry.

[46]  Krzysztof Palczewski,et al.  Oligomerization of G protein-coupled receptors: past, present, and future. , 2004, Biochemistry.

[47]  Mark S.P. Sansom,et al.  Hinges, swivels and switches: the role of prolines in signalling via transmembrane α-helices , 2000 .

[48]  Marta Filizola,et al.  Crosstalk in G protein-coupled receptors: changes at the transmembrane homodimer interface determine activation. , 2005, Proceedings of the National Academy of Sciences of the United States of America.

[49]  M. le Maire,et al.  Monomeric G-protein-coupled receptor as a functional unit. , 2005, Biochemistry.

[50]  H. Hamm,et al.  Mechanism of action of monoclonal antibodies that block the light activation of the guanyl nucleotide-binding protein, transducin. , 1987, The Journal of biological chemistry.

[51]  T. Costa,et al.  Agonist Efficacy and Aliosteric Models of Receptor Action a , 1997, Annals of the New York Academy of Sciences.

[52]  J. Ballesteros,et al.  [19] Integrated methods for the construction of three-dimensional models and computational probing of structure-function relations in G protein-coupled receptors , 1995 .

[53]  T. Okada X-ray crystallographic studies for ligand-protein interaction changes in rhodopsin. , 2004, Biochemical Society transactions.

[54]  Z. Salamon,et al.  Surface plasmon resonance spectroscopy studies of membrane proteins: transducin binding and activation by rhodopsin monitored in thin membrane films. , 1996, Biophysical journal.

[55]  K. Fahmy,et al.  Transducin-dependent protonation of glutamic acid 134 in rhodopsin. , 2000, Biochemistry.

[56]  Francesca Fanelli,et al.  Quaternary structure predictions of transmembrane proteins starting from the monomer: a docking-based approach , 2006, BMC Bioinformatics.

[57]  J. Ballesteros,et al.  Beta2 adrenergic receptor activation. Modulation of the proline kink in transmembrane 6 by a rotamer toggle switch. , 2002, The Journal of biological chemistry.

[58]  J. Martens,et al.  Insight into mutation-induced activation of the luteinizing hormone receptor: molecular simulations predict the functional behavior of engineered mutants at M398. , 2004, Molecular endocrinology.

[59]  Francesca Fanelli,et al.  Mutagenesis and modelling of the alpha(1b)-adrenergic receptor highlight the role of the helix 3/helix 6 interface in receptor activation. , 2002, Molecular pharmacology.

[60]  M. Ascoli,et al.  The lutropin/choriogonadotropin receptor, a 2002 perspective. , 2002, Endocrine reviews.

[61]  Krzysztof Palczewski,et al.  Role of the conserved NPxxY(x)5,6F motif in the rhodopsin ground state and during activation , 2003, Proceedings of the National Academy of Sciences of the United States of America.

[62]  Francesca Fanelli,et al.  Computational modeling approaches to structure-function analysis of G protein-coupled receptors. , 2005, Chemical reviews.

[63]  G. Milligan,et al.  Oligomerisation of G-protein-coupled receptors. , 2001, Journal of cell science.

[64]  A. Scheer,et al.  Constitutively active mutants of the alpha 1B‐adrenergic receptor: role of highly conserved polar amino acids in receptor activation. , 1996, The EMBO journal.

[65]  A. Scheer,et al.  Mutational analysis of the highly conserved arginine within the Glu/Asp-Arg-Tyr motif of the alpha(1b)-adrenergic receptor: effects on receptor isomerization and activation. , 2000, Molecular pharmacology.

[66]  M. Bouvier,et al.  Roles of G‐protein‐coupled receptor dimerization , 2004, EMBO reports.

[67]  M. Parenti,et al.  Mutational Analysis of the Highly Conserved ERY Motif of the Thromboxane A2 Receptor: Alternative Role in G Protein-Coupled Receptor Signaling , 2004, Molecular Pharmacology.

[68]  L. Limbird,et al.  G protein-coupled receptor interacting proteins: emerging roles in localization and signal transduction. , 2002, Cellular signalling.

[69]  Terry Kenakin,et al.  Efficacy at g-protein-coupled receptors , 2002, Nature Reviews Drug Discovery.

[70]  T. Schwartz,et al.  High Constitutive Activity of a Virus-Encoded Seven Transmembrane Receptor in the Absence of the Conserved DRY Motif (Asp-Arg-Tyr) in Transmembrane Helix 3 , 2005, Molecular Pharmacology.

[71]  A. Themmen,et al.  Lutropin Receptor Function: Insights from Natural, Engineered, and Computer‐Simulated Mutations , 2001, IUBMB life.

[72]  H Weinstein,et al.  Functional role of a conserved motif in TM6 of the rat mu opioid receptor: constitutively active and inactive receptors result from substitutions of Thr6.34(279) with Lys and Asp. , 2001, Biochemistry.

[73]  Francesca Fanelli,et al.  Rhodopsin activation follows precoupling with transducin: inferences from computational analysis. , 2005, Biochemistry.

[74]  K. Palczewski,et al.  Activation of rhodopsin: new insights from structural and biochemical studies. , 2001, Trends in biochemical sciences.

[75]  M. Menziani,et al.  Molecular dynamics simulations of m3-muscarinic receptor activation and QSAR analysis. , 1995, Bioorganic & medicinal chemistry.

[76]  F Guarnieri,et al.  Activation of the cannabinoid CB1 receptor may involve a W6 48/F3 36 rotamer toggle switch. , 2002, The journal of peptide research : official journal of the American Peptide Society.

[77]  Michel Bouvier,et al.  Oligomerization of G-protein-coupled transmitter receptors , 2001, Nature Reviews Neuroscience.

[78]  L. Pardo,et al.  A molecular dissection of the glycoprotein hormone receptors. , 2004, Trends in biochemical sciences.

[79]  C. Rommel,et al.  The DRY motif as a molecular switch of the human oxytocin receptor. , 2005, Biochemistry.

[80]  M. Scarselli,et al.  The impact of G‐protein‐coupled receptor hetero‐oligomerization on function and pharmacology , 2005, The FEBS journal.

[81]  A. Scheer,et al.  Ab initio modeling and molecular dynamics simulation of the alpha 1b-adrenergic receptor activation. , 1998, Methods.

[82]  F. Fanelli,et al.  Theoretical study on mutation-induced activation of the luteinizing hormone receptor. , 2000, Journal of molecular biology.

[83]  A. Scheer,et al.  Theoretical study of the electrostatically driven step of receptor‐G protein recognition , 1999, Proteins.

[84]  Marcus Elstner,et al.  The retinal conformation and its environment in rhodopsin in light of a new 2.2 A crystal structure. , 2004, Journal of molecular biology.

[85]  Paul D. Scott,et al.  Dimerization of G-protein-coupled receptors. , 2001 .

[86]  Paul D. Scott,et al.  Entropy and oligomerization in GPCRs , 2007, Journal of Molecular Neuroscience.

[87]  Velin Z. Spassov,et al.  Introducing an Implicit Membrane in Generalized Born/Solvent Accessibility Continuum Solvent Models , 2002 .

[88]  J. Ballesteros,et al.  Structural motifs as functional microdomains in G-protein-coupled receptors: Energetic considerations in the mechanism of activation of the serotonin 5-HT2A receptor by disruption of the ionic lock of the arginine cage* , 2002 .

[89]  Francesca Fanelli,et al.  Molecular Dynamics Simulations of the Ligand-Induced Chemical Information Transfer in the 5-HT1A Receptor , 2003, J. Chem. Inf. Comput. Sci..

[90]  H. Khorana,et al.  Requirement of Rigid-Body Motion of Transmembrane Helices for Light Activation of Rhodopsin , 1996, Science.